India, Sept. 9 -- HDFC Asset Management Company Limited (HDFC AMC), the investment manager of HDFC Mutual Fund (HDFC MF) and ...

The fund, according to the AMC, seeks to capitalize on India's evolving healthcare ecosystem, which is being shaped by favourable demographics, expanding healthcare access, rising insurance ...

Ten pharma and healthcare mutual funds delivered more than 20% returns in the past year, with HDFC Pharma And Healthcare Fund ...

Invesco India Pharma and Healthcare Fund launches, investing across pharma, hospitals, diagnostics, and more. NFO opens August 18.

A sharp reversal has reshaped the mutual fund leaderboard in 2026, with many of last year's best-performing categories slipping. Here's what the latest data shows and why experts say investors should ...

HDFC Pharma and Healthcare Fund posted a 30.19 percent CAGR since inception and a 19.01 percent one-year return, supported by ...

Over the past 1-year, the healthcare and pharma funds have produced impressive performance, with returns ranging from 20.93% to 29.8%, surpassing both the category average of 20.7% and the BSE ...

Nippon India Pharma Fund is a Equity mutual fund categorized under Sector, offered by Nippon Life India Asset Management Ltd.. Launched on 05 Jun 2004, investors can start with a minimum SIP of ₹100 .